Bivigam Interactions
There are 107 drugs known to interact with Bivigam (immune globulin intravenous), along with 3 disease interactions. Of the total drug interactions, 86 are major, and 21 are moderate.
- View all 107 medications that may interact with Bivigam
- View Bivigam disease interactions (3)
Most frequently checked interactions
View interaction reports for Bivigam (immune globulin intravenous) and the medicines listed below.
- azelastine nasal
- baclofen
- Benadryl (diphenhydramine)
- ciprofloxacin
- Deplin (l-methylfolate)
- Eliquis (apixaban)
- estradiol
- famotidine
- folic acid
- furosemide
- gabapentin
- hydroxychloroquine
- ibuprofen
- levothyroxine
- losartan
- magnesium citrate
- magnesium oxide
- melatonin
- metoprolol
- omeprazole
- ondansetron
- prednisone
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- valacyclovir
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Bivigam disease interactions
There are 3 disease interactions with Bivigam (immune globulin intravenous) which include:
Report options
QR code containing a link to this page
More about Bivigam (immune globulin intravenous)
- Bivigam consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.